AI & Molecular Diagnostics Reshaping Cervical Cancer Screening Market According to a newly published market research report by 24LifeSciences, global cervical cancer diagnostic testing market was valued at USD 6.19 billion in 2025 and is projected to grow from USD 6.47 billion in 2026 to reach USD 8.44 billion by 2034, growing at a compound annual growth rate (CAGR) of 4.6% during the forecast period. Cervical cancer diagnostic tests are essential medical procedures designed to detect precancerous and cancerous conditions in the cervix. These tests are critical for early intervention because cervical cancer is primarily caused by persistent infection with high-risk human papillomavirus (HPV) strains. The primary diagnostic modalities include Pap smear tests (Pap cytology), HPV DNA tests, colposcopy, and cervical biopsies, which are fundamental components of routine gynecological screening programs worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9355/cervical-cancer-diagnostic-testing-market

How Rapid and Molecular Diagnostics Are Shaping the Brucellosis Test Kits Market According to a newly published market research report by 24LifeSciences, global brucellosis test kits market is valued at USD 315.7 million in 2026 and is projected to reach USD 458.6 million by 2034, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period. Brucellosis test kits are in-vitro diagnostic (IVD) tools designed for the serological detection of antibodies against Brucella bacteria, a critical component in diagnosing both human and animal brucellosis. These kits play an essential role in managing this zoonotic disease, which causes significant economic losses in livestock production and poses serious public health risks. The most common formats include Brucella IgG, IgM, and IgA ELISA kits, along with traditional methods like rose bengal plate tests (RBPT) and advanced fluorescence polarization assays (FPA). Their accuracy and reliability make them indispensable for veterinary diagnostics, food safety programs, and human healthcare systems worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9628/brucellosis-test-kits-market

What Is the Future of the INAAT Market? Growth Forecasts & Molecular Diagnostics Insights Global Isothermal Nucleic Acid Amplification Technology (INAAT) market is undergoing rapid transformation as healthcare systems increasingly prioritize fast, accurate, and decentralized diagnostic solutions. Valued at USD 6.49 billion in 2024, the market is projected to reach USD 12.02 billion by 2031, expanding at a CAGR of 9.4% during the forecast period. This sustained growth reflects rising demand for point-of-care molecular diagnostics, expanding infectious disease surveillance, and continuous innovation in amplification technologies that operate without complex thermal cycling. Read the full analysis https://www.24lifesciences.com/isothermal-nucleic-acid-amplification-technology-inaat-market-8419

Molecular Diagnostics Point of Care Market Size, Major Players, Revenue Analysis, 2021–2032 The Global Molecular Diagnostics Point of Care Market is projected to reach USD 4.84 billion in 2027 To know more about the report, visit @ https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market